Keyword : multiple myeloma
Indications for hematopoietic cell transplantation for lymphoproliferative blood diseases: current practice in Europe, 2022Authors: Tsyapka O.M. Tushnytskyi O.M. Zalokotska L.V. Savuliak H.R.... Т. 13, № 3 (51)
Modern tactics of treatment of relapsed/refractory multiple myelomaAuthor:Nemish I.L. Т. 13, № 3 (51)
Multiple myeloma associated secondary systemic AL-amyloidosis: a case report and a literature reviewAuthors: Rudiuk T. Novosad O. Shevchuk L. Kundina V.... Т. 11, № 1-2 (41-42)
Experience of conducting high dose chemotherapy and autologous stem cell transplantation for adult patients at the National Cancer Institute of Ukraine
Authors: Kushchevyi E.V. Filonenko K.S. Martynchyk A.V. Kryachok I. T. 10, № 1-2 (37-38)
Authors: Kushchevyi E.V. Filonenko K.S. Martynchyk A.V. Kryachok I. T. 10, № 1-2 (37-38)
Review of 15 International Conference on Malignant Lymphoma (ICML), Lugano, Switzerland, 18–22 of June, 2019
Authors: Martynchyk A.V. Kryachok I. Т. 9, № 3 (35) 2019
Authors: Martynchyk A.V. Kryachok I. Т. 9, № 3 (35) 2019
Changing the Treatment Landscape of multiple myeloma (2003–2013). Own resultsAuthors: Novosad O. Kryachok I. Ulianchenko K.O. Skripets Т.V.... Т. 9, № 2 (34) 2019
The role of hematopoietic stem cell transplantation in the treatment of multiple myelomaAuthors: Kryachok I. Kushchevyi E.V. №3(27) 2017
Molecular-genetic characteristics of patients with multiple myeloma in UkraineAuthors: Kostyukova N.I. Rossokha Z.I. Pilipenko G.V. Yermolytskaya I.P.... №1(9) 2013
The experience of the treatment of patient with relapsed and refractory lymphoma with salvage-therapyAuthors: Kushchevyi E.V. Martynchyk A.V. Filonenko Е. Novosad I.O.... №2 (2) 2011
Treatment of patients with relapse or refractory Hodgkin’s disease.Role of high dose chemotherapy and haemopoietic stem cell transplantation
